Genetic Variations and Association

International Review of Neurobiology

Volumn 94, Issue C, 2010, Pages 129-151

  Gennarelli, Massimo ^a   Cattaneo, Annamaria ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CLOZAPINE; MESSENGER RNA; NEUROLEPTIC AGENT; RISPERIDONE; SEROTONIN 6 RECEPTOR; TRANSCRIPTION FACTOR;

ALZHEIMER DISEASE; BOOK; DEPRESSION; DNA SEQUENCE; DRUG MECHANISM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE INTERACTION; GENE MAPPING; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; MOLECULAR CLONING; MOOD DISORDER; NONHUMAN; NUCLEOTIDE SEQUENCE; PHARMACOGENETICS; PRIORITY JOURNAL; SCHIZOPHRENIA; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 78349258127     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-384976-2.00006-X     Document Type: Chapter

References (53)

1. D9 receptor. Mol. Pharmacol. 1992, 41:17.
2. Alvarez-Alvarez M., Galdos L., Fernández-Martínez M., Gómez-Busto F., García-Centeno V., Arias-Arias C., Sánchez-Salazar C., Rodríguez-Martínez A.B., Zarranz J.J., de Pancorbo M.M. 5-Hydroxytryptamine 6 receptor (5-HT(6)) receptor and apolipoprotein E (ApoE) polymorphisms in patients with Alzheimer's disease in the Basque Country. Neurosci. Lett. 2003, 339:85-87.
3. Andreadis A., Gallego M.E., Nadal-Ginardi B. Generation of protein isoform diversity by alternative splicing: mechanistic and biological implications. Annu Rev. Cell. Biol. 1987, 31987:207-242.
4. Bandiera S., Hatem E., Lyonnet S., Henrion-Caude A. MicroRNAs in diseases: from candidate to modifier genes. Clin. Genet. 2010, 77:306-313.
5. Chatzikyriakidou A., Voulgari P.V., Georgiou I., Drosos A.A. The role of microRNA-146a (miR-146a) and its target IL-1R-associated kinase (IRAK1) in psoriatic arthritis susceptibility. Scand. J. Immunol. 2010, 71:382-385.
6. Cheng R., Juo S.H., Loth J.E., Nee J., Iossifov I., Blumenthal R., Sharpe L., Kanyas K., Lerer B., Lilliston B., Smith M., Trautman K., Gilliam T.C., Endicott J., Baron M. Genome-wide linkage scan in a large bipolar disorder sample from the National Institute of Mental Health genetics initiative suggests putative loci for bipolar disorder, psychosis, suicide, and panic disorder. Mol. Psychiatry 2006, 11:252-260.
7. Chiu H.J., Wang Y.C., Liou J.H., Chao C.H., Lee H., Tsai K.Y., Liu W.C. Serotonin 6 receptor polymorphism in schizophrenia: frequency, age at onset and cognitive function. Neuropsychobiology 2001, 43:113-116.
8. DeMichele-Sweet M.A., Sweet R.A. Genetics of psychosis in Alzheimer's disease: a review. J. Alzheimers Dis. 2010, 19:761-780.
9. Fukuo Y., Kishi T., Yoshimura R., Kitajima T., Okochi T., Yamanouchi Y., Kinoshita Y., Kawashima K., Naitoh H., Umene-Nakano W., Inada T., Kunugi H., Kato T., Yoshikawa T., Ujike H., Nakamura J., Ozaki N., Iwata N. Serotonin 6 receptor gene and mood disorders: case-control study and meta-analysis. Neurosci. Res. 2010, 67:250-255.
10. Garcia-Alloza M., Hirst W.D., Chen C.P., Lasheras B., Francis P.T., Ramirez M.J. Differential involvement of 5-HT (1B/1D) and 5-HT6 receptors in cognitive and non-cognitive symptoms in Alzheimer's disease. Neuropsychopharmacology 2004, 29:410-416.
11. Geldenhuys W.J., Van der Schyf C.J. The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's disease. Expert Rev. Neurother. 2009, 9:1073-1085.
12. Gerard C., Martres M.P., Lefevre K., Miquel M.C., Verge D., Lanfumey L., Doucet E., Hamon M., el Mestikawy S. Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system. Brain Res. 1997, 746:207-219.
13. Harmer C.J. Serotonin and emotional processing: does it help explain antidepressant drug action?. Neuropharmacology 2008, 55:1023-1028.
14. Hirst W.D., Abrahamsen B., Blaney F.E., Calver A.R., Aloj L., Price G.W., Medhurst A.D. Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling. Mol. Pharmacol. 2003, 64:1295-1308.
15. Hong C.J., Tsai S.J., Cheng C.Y., Liao W.Y., Song H.L., Lai H.C. Association analysis of the 5-HT(6) receptor polymorphism (C267T) in mood disorders. Am. J. Med. Genet. 1999, 88:601-602.
16. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Myleeharane E.J., Saxena P.R., Humphrey P.P.A. VII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 1994, 46:157-203.
17. Humphrey P.P.A., Hartig P., Hoyer D. A proposed new nomenclature for 5-HT receptors. Trends Pharmacol. Sci. 1993, 14:233-236.
18. Ikeda M., Yamanouchi Y., Kinoshita Y., Kitajima T., Yoshimura R., Hashimoto S., O'Donovan M.C., Nakamura J., Ozaki N., Iwata N. Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia. Pharmacogenomics 2008, 9:1437-1443.
19. Illi A., Setala-Soikkeli E., Viikki M., Poutanen O., Huhtala H., Mononen N., Lehtimaki T., Leinonen E., Kampman O. 5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression. Neuroreport 2009, 20:1125-1128.
20. Kan R., Wang B., Zhang C., Yang Z., Ji S., Lu Z., Zheng C., Jin F., Wang L. Association of the HTR6 polymorphism C267T with late-onset Alzheimer's disease in Chinese. Neurosci. Lett. 2004, 372:27-29.
21. Kato T. Molecular genetics of bipolar disorder and depression. Psychiatry Clin. Neurosci. 2007, 61:3-19.
22. Kohen R., Metcalf M.A., Khan N., Druck T., Huebner K., Lachowicz J.E., Sibley D.R., Roth B.L., Hamblin M.W. Cloning, characterization and chromosomal localization of a human 5-HT6 serotonin receptor. J. Neurochem. 1996, 66:47-56.
23. Kulkarni S.K., Dhir A. Current investigational drugs for major depression. Expert Opin. Investig. Drugs 2009, 18:767-788.
24. Lane H.Y., Lin C.C., Huang C.H., Chang Y.C., Hsu S.K., Chang W.H. Risperidone response and 5-HT6 receptor gene variance: genetic association analysis with adjustment for nongenetic confounders. Schizophr. Res. 2004, 67:63-70.
25. Le Francois B., Czesak M., Steubl D., Albert P.R. Transcriptional regulation at a HTR1A polymorphism associated with mental illness. Neuropharmacology 2008, 55:977-985.
26. Lee S.H., Lee K.J., Lee H.J., Ham B.J., Ryu S.H., Lee M.S. Association between the 5-HT6 receptor C267T polymorphism and response to antidepressant treatment in major depressive disorder. Psychiatry Clin. Neurosci. 2005, 59:140-145.
27. Levinson D.F. The genetics of depression: a review. Biol. Psychiatry. 2006, 60:84-92.
28. Liu H.C., Hong C.J., Liu C.Y., Lin K.N., Tsai S.J., Liu T.Y., Chi C.W., Wang P.N. Association analysis of the 5-HT6 receptor polymorphism C267T with depression in patients with Alzheimer's disease. Psychiatry Clin. Neurosci. 2001, 55:427-429.
29. Masellis M., Basile V.S., Meltzer H.Y., Lieberman J.A., Sevy S., Goldman D.A., Hamblin M.W., Macciardi F.M., Kennedy J.L. Lack of association between the T->C 267 serotonin 5-HT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia. Schizophr. Res. 2001, 47:49-58.
30. Monsma F.J., Shen Y., Ward R.P., Hamblin M.W., Sibley D.R. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol. Pharmacol. 1993, 43:320-327.
31. Mount S.M. A catalogue of splice junction sequences. Nucleic Acids Res. 1982, 10:459-472.
32. Murray B.S., Choe S.E., Woods M., Ryan T.E., Liu W. An in silico analysis of microRNAs: mining the miRNAome. Mol. Biosyst. 2010, 10:1853-1862.
33. Nash M.W., Huezo-Diaz P., Williamson R.J., Sterne A., Purcell S., Hoda F., Cherny S.S., Abecasis G.R., Prince M., Gray J.A., Ball D., Asherson P., Mann A., Goldberg D., McGuffin P., Farmer A., Plomin R., Craig I.W., Sham P.C. Genomewide linkage analysis of a composite index of neuroticism and mood-related scales in extreme selected sibships. Hum. Mol. Genet. 2004, 13:2173-2182.
34. Ohmori O., Shinkai T., Hori H., Nakamura J. Novel polymorphism in the 5'-upstream region of the human 5-HT6 receptor gene and schizophrenia. Neurosci. Lett. 2001, 310:17-20.
35. Olsen M.A., Nawoschik S.P., Schurman B.R., Schmitt H.L., Burno M., Smith D.L., Schechter L.E. Identification of a human 5-HT6 receptor variant produced by alternative splicing. Brain Res. Mol. Brain Res. 1999, 64:255-263.
36. Orlacchio A., Kawarai T., Paciotti E., Stefani A., Orlacchio A., Sorbi S., St George-Hyslop P.H., Bernardi G. Association study of the 5-hydroxytryptamine (6) receptor gene in Alzheimer's disease. Neurosci. Lett. 2002, 325:13-16.
37. Roth B.L., Craigo S.C., Choudhary M.S., Uluer A., Monsma F.J., Shen Y., Meltzer H.Y., Sibley D.R. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol. Exp. Ther. 1994, 268:1403-1410.
38. Ryan B.M., Robles A.I., Harris C.C. Genetic variation in microRNA networks: the implications for cancer research. Nat. Rev. Cancer. 2010, 10:523.
39. Schoeffter P., Waeber C. 5-Hydroxytryptamine receptors with a 5-UT6 receptor-like profile stimulating adenylyl cyclase activity in pig caudate membranes. Arch. Pharmacol. 1994, 350:356-360.
40. Schumacher J., Kaneva R., Jamra R.A., Diaz G.O., Ohlraun S., Milanova V., Lee Y.A., Rivas F., Mayoral F., Fuerst R., Flaquer A., Windemuth C., Gay E., Sanz S., Gonzalez M.J., Gil S., Cabaleiro F., del Rio F., Perez F., Haro J., Kostov C., Chorbov V., Nikolova-Hill A., Stoyanova V., Onchev G., Kremensky I., Strauch K., Schulze T.G., Nurnberg P., Gaebel W., Klimke A., Auburger G., Wienker T.F., Kalaydjieva L., Propping P., Cichon S., Jablensky A., Rietschel M., Nothen M.M. Genomewide scan and fine-mapping linkage studies in four European samples with bipolar affective disorder suggest a new susceptibility locus on chromosome 1p35-p36 and provides further evidence of loci on chromosome 4q31 and 6q24. Am. J. Hum. Genet. 2005, 77:1102-1111.
41. Shinkai T., Ohmori O., Kojima H., Terao T., Suzuki T., Abe K. Association study of the 5-HT6 receptor gene in schizophrenia. Am. J. Hum. Genet. 1999, 88:120-122.
42. Sleight A.J., Boess F.G., Bös M., Bourson A. The putative 5-ht6 receptor: localization and function. Ann. N. Y. Acad. Sci. 1998, 861:91-96.
43. Thome J., Retz W., Baader M., Pesold B., Hu M., Cowen M., Durany N., Adler G., Henn F.A., Rösler M. Association analysis of HTR6 and HTR2A polymorphisms in sporadic Alzheimer's disease. J. Neural. Trans. 2001, 108:1175-1180.
44. Tsai S.J., Chiu H.J., Wang Y.C., Hong C.J. Association study of serotonin-6 receptor variant (C267T) with schizophrenia and aggressive behavior. Neurosci. Lett. 1999, 271:135-137.
45. Tsai S.J., Liu H.C., Liu T.Y., Wang Y.C., Hong C.J. Association analysis of the 5-HT6 receptor polymorphism C267T in Alzheimer's disease. Neurosci. Lett. 1999, 276:138-139.
46. Vazza G., Bertolin C., Scudellaro E., Vettori A., Boaretto F., Rampinelli S., De Sanctis G., Perini G., Peruzzi P., Mostacciuolo M.L. Genome-wide scan supports the existence of a susceptibility locus for schizophrenia and bipolar disorder on chromosome 15q26. Mol. Psychiatry 2007, 12:87-93.
47. Vogt I.R., Shimron-Abarbanell D., Neidt H., Erdmann J., Cichon S., Schulze T.G., Müller D.J., Maier W., Albus M., Borrmann-Hassenbach M., Knapp M., Rietschel M., Propping P., Nöthen M.M. Investigation of the human serotonin 6 [5-HT6] receptor gene in bipolar affective disorder and schizophrenia. Am. J. Med. Genet. 2000, 96:217-221.
48. Wesolowska A., Nikiforuk A. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression. Neuropharmacology 2007, 52:1274-1283.
49. Wesolowska A., Nikiforuk A., Stachowicz K. Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats. Behav. Pharmacol. 2007, 18:439-446.
50. Wilkie M.J., Smith G., Day R.K., Matthews K., Smith D., Blackwood D., Reid I.C., Wolf C.R. Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy. J. Pharmacogenomics 2009, 9:61-70.
51. Wu W.H., Huo S.J., Cheng C.Y., Hong C.J., Tsai S.J. Association study of the 5-HT(6) receptor polymorphism (C267T) and symptomatology and antidepressant response in major depressive disorders. Neuropsychobiology 2001, 44:172-175.
52. Xu Y., Liu H., Li F., Sun N., Ren Y., Liu Z., Cao X., Wang Y., Liu P., Zhang K. A polymorphism in the microRNA-30e precursor associated with major depressive disorder risk and P300 waveform. J. Affect. Disord. 2010, [Epub ahead of print].
53. Yu Y.W., Tsai S.J., Lin C.H., Hsu C.P., Yang K.H., Hong C.J. Serotonin-6 receptor variant (C267T) and clinical response to clozapine. Neuroreport 1999, 10:1231-1233.